Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.66 USD | -1.42% | -20.46% | -8.56% |
May. 09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
May. 08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.56% | 329M | |
+8.93% | 33.98B | |
+21.06% | 8.16B | |
+32.48% | 4.26B | |
-18.12% | 1.4B | |
-28.50% | 1.27B | |
-33.58% | 1.17B | |
+11.28% | 1.02B | |
-33.89% | 917M | |
-22.36% | 660M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- B. Riley Securities Lifts LifeMD's PT to $12 From $11 After 'Strong' Q4 2023 Results, Maintains Buy Rating